CN102267941A - 一种苯乙烯衍生物及其制备方法 - Google Patents

一种苯乙烯衍生物及其制备方法 Download PDF

Info

Publication number
CN102267941A
CN102267941A CN2011101203599A CN201110120359A CN102267941A CN 102267941 A CN102267941 A CN 102267941A CN 2011101203599 A CN2011101203599 A CN 2011101203599A CN 201110120359 A CN201110120359 A CN 201110120359A CN 102267941 A CN102267941 A CN 102267941A
Authority
CN
China
Prior art keywords
formula
preparation
pyridine
compound
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011101203599A
Other languages
English (en)
Inventor
张玉红
于明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang University ZJU
Original Assignee
Zhejiang University ZJU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang University ZJU filed Critical Zhejiang University ZJU
Priority to CN2011101203599A priority Critical patent/CN102267941A/zh
Publication of CN102267941A publication Critical patent/CN102267941A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种苯乙烯衍生物,其结构如式(I)或(II)所示,式(I)和(II)中R1为甲基、烷氧基、卤原子、H;R2为H、烷氧基、酰氧基,硝基、卤原子;R3为C1~C4烷基。本发明还公开了上述苯乙烯衍生物的制备方法,包括:搅拌条件下,将2-(苯基亚砜)吡啶化合物、苯乙烯化合物或丙烯酸酯化合物、醋酸钯、醋酸银加入到乙腈中,50~130℃反应完全。本发明采用易得的原料制备得到苯乙烯衍生物,反应选择性好,反应条件温和,制备工艺简单,生产成本低,整条合成路线环境友好。

Description

一种苯乙烯衍生物及其制备方法
技术领域
本发明涉及有机化合物中间体制备领域,尤其涉及一种苯乙烯衍生物及其制备方法。
背景技术
苯乙烯衍生物,特别是1,2-二苯乙烯衍生物和苯丙烯酸酯衍生物是天然产物中一种常用的结构单元,具有良好的生物抗癌活性;另一方面1,2-二苯乙烯衍生物和苯丙烯酸酯衍生物也是良好的材料结构单元。目前,文献所报道的1,2-二苯乙烯衍生物和苯丙烯酸酯衍生物的制备方法主要有以下方法:利用钯催化剂,卤代芳烃和烯烃的Heck反应(Beletskaya,I.P.;Cheprakov.A.V.Chem.Rev.2000,100,3009.),此法步骤繁多,且制备过程中使用了多种试剂,对环境污染严重;Fujiwara等(Moritani,I.;Fujiwara,Y.Tetrahedron Lett.1967,8,1119)报道了不活泼的芳烃C-H直接和烯烃的氧化偶联反应,但反应的选择性不佳,Yu,J.-Q等报道了含引导基的芳烃C-H直接和烯烃的氧化偶联反应(Wasa,M.;Engle,K.M.;Yu,J.-Q.J.Am.Chem.Soc.2010,132,3680),虽解决了选择性的问题,但引导基不容易除去是其缺点。因此选择更为高效的开发一种合成1,2-二苯乙烯衍生物和苯乙烯酸酯衍生物的绿色方法是非常有必要和有经济价值的。
近年来,利用钯催化有机转化工艺研究取得了巨大发展。如钯催化的Heck反应,Suzuki反应等已经成为有机合成的重要方法,在工业上已得到广泛应用。进一步拓展了钯催化反应,尤其是钯催化的直接C-H活化反应药物中间体的合成引起了世界范围内的广泛关注。利用钯等催化剂开发众多药物中间体的绿色合成新工艺具备良好的经济效益、环境效益和工业化前景,有望应用于众多化工产品及医药产品的合成和生产。
发明内容
本发明提供了一种重要的有机合成中间体苯乙烯衍生物,该衍生物是天然产物中一种常用的结构单元,具有良好的生物抗癌活性;另一方面1,2-二苯乙烯衍生物和苯丙烯酸酯衍生物也是良好的材料结构单元。本发明还提供了上述苯乙烯衍生物的制备方法,该方法制备工艺简单,环境友好且收率较高。
一种苯乙烯衍生物,其结构如式(I)或(II)所示:
Figure BDA0000060416890000021
式(I)或(II)中:R1为甲基、烷氧基、卤原子、H;R2为H、烷氧基、烷酰氧基、硝基、卤原子;R3为C1~C4的烷基。
优选的,(I)和(II)中R1为甲基、甲氧基、氯原子、H;R2为H或甲氧基、乙酰氧基、硝基、卤原子;R3为甲基、乙基、正丁基。
进一步优选的,式(I)或(II)所示的化合物为下列化合物之一:
Figure BDA0000060416890000022
Figure BDA0000060416890000031
Figure BDA0000060416890000051
一种苯乙烯衍生物的制备方法,包括:搅拌条件下,将2-(苯基亚砜)吡啶(III)、苯乙烯化合物(IV)或丙烯酸酯化合物(V)、醋酸钯、醋酸银加入到乙腈中,50~130℃反应完全,反应过程如下式所示:
Figure BDA0000060416890000052
上式中,R1为甲基、烷氧基、卤原子、H;R2为H、烷氧基、酰氧基,硝基、卤原子;R3为C1~C4烷基。
优选的,式(III)所示的化合物选自2-(苯基亚砜)吡啶、2-(2-甲基苯基亚砜)吡啶、2-(4-甲基苯基亚砜)吡啶、2-(3-甲氧基苯基亚砜)吡啶、2-(4-甲氧基苯基亚砜)吡啶或2-(4-氯苯基亚砜)吡啶;所述的式(IV)所示的化合物选自苯乙烯、3-硝基苯乙烯、五氟苯乙烯、4-氟苯乙烯、3-氟苯乙烯、4-溴苯乙烯、4-乙酰氧基苯乙烯或4-甲氧基苯乙烯;所述的式(V)所示的化合物选自丙烯酸甲酯、丙烯酸乙酯或丙烯酸正丁酯。
所述的2-(苯基亚砜)吡啶化合物(III)与醋酸钯的摩尔比为1∶0.1~0.5;2-(苯基亚砜)吡啶化合物(III)与苯乙烯化合物(IV)或丙烯酸酯化合物(V)的摩尔比为1∶1~8;2-(苯基亚砜)吡啶化合物(III)与醋酸银(AgOAc)的摩尔比为1∶1~5;反应时间为8~25小时。反应过程中醋酸钯作为催化剂,醋酸银作为氧化剂,可以选用市售产品,2-(苯基亚砜)吡啶化合物可采用文献报道方法(Richter,H.Beckendorf,S.
Figure BDA0000060416890000061
O.G.Adv.Synth.Catal.2011,353,295)制备。
本发明的有益效果体现在:本发明采用易得的原料制备得到苯乙烯衍生物,反应选择性好,反应条件温和,制备工艺简单,生产成本低,整条合成路线环境友好。
具体实施方式
实施例1~10
按照表1的原料配比,称取2-(苯基亚砜)吡啶(III),苯乙烯化合物(IV)、醋酸钯、醋酸银和乙腈于25ml的圆底烧瓶中,常压空气下,按照表1的反应条件反应完全,然后将溶剂旋干,得到的粗产品经柱层析(石油醚/乙酸乙酯=3/1)纯化得到最终产品,反应过程如下式所示:
表1
Figure BDA0000060416890000071
其中,III加入量为1mmol,Et为乙基,OAc为乙酰氧基,OMe为甲氧基,T为反应温度,t为反应时间。
实施例11~20
按照表2的原料配比,称取2-(苯基亚砜)吡啶化合物(III),丙烯酸酯化合物(V)、醋酸钯、醋酸银和乙腈于25ml的圆底烧瓶中,常压空气下,按照表2的反应条件反应完全,然后将溶剂旋干,得到的粗产品经柱层析(石油醚/乙酸乙酯=3/1)纯化得到最终产品,反应过程如下式所示:
表2
Figure BDA0000060416890000073
Figure BDA0000060416890000081
其中,III加入量为1mmol,V加入量:实施例12~18为2.5mmol,实施例19为5mmol,实施例20为8mmol,Et为乙基,n-Bu为正丁基,OMe为甲氧基,T为反应温度,反应时间为12小时。
结构确认数据
由实施例1~8(表1)制备得到的1,2-二苯乙烯衍生物的结构检测数据分别为:
由实施例1制备得到的1,2-二苯乙烯衍生物(I-1)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000082
性状:白色固体;
熔点:99-100℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.48(s,1H),8.01(d,J=8.4Hz,1H),7.93(d,J=16.4Hz,1H),7.90(d,J=7.6Hz,1H),7.84(t,J=8.0Hz,1H),7.69(d,J=7.6Hz,1H),7.57(d,J=7.6Hz,2H),7.44-7.37(m,4H),7.30(t,J=6.8Hz,1H),7.26-7.24(m,1H),7.05(d,J=16.0Hz,1H).
13C NMR(100MHz,CDCl3)δ165.9,149.5,141.8,137.8,137.1,136.8,132.1,131.2,128.6,128.3,128.1,126.9,125.9,125.1,124.5,123.9,119.1.
HRMS(EI)计算值:C19H15NOS(M+)305.0874,检测值:305.0874.
由实施例2制备得到的1,2-二苯乙烯衍生物(I-2)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000091
性状:黄色固体;
熔点:78-80℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.47(d,J=4.0Hz,1H),8.02(d,J=8.0Hz,1H),7.94(d,J=16.0Hz,1H),7.89(dd,J1=8.0Hz,J2=1.2Hz,1H),7.83(td,J1=8.0Hz,J2=1.6Hz,1H),7.68-7.66(m,1H),7.46-7.39(m,2H),7.34-7.31(m,2H),7.28-7.23(m,2H),7.00(d,J=16.0Hz,1H),7.03-6.96(m,1H).
13C NMR(100MHz,CDCl3)δ165.8,163.1(d,J=244.8Hz,C-F),149.5,142.0,139.1(d,J=7.3Hz,1C),137.9,137.4,136.6,131.3,130.7(d,J=2.8Hz,1C),130.0(d,J=8.5Hz,1C),128.6,125.9,125.3,124.5,122.7(d,J=2.6,Hz 1C),119.0,114.8(d,J=23.1Hz,1C),113.2(d,J=20.8Hz,1C).
HRMS(EI)计算值:C19H14FNOS(M+)323.0780,检测值:323.0782.
由实施例3制备得到的1,2-二苯乙烯衍生物(I-3)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000092
性状:黄色固体;
熔点:75-76℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.47(d,J=2.4Hz,1H),8.02(d,J=7.6Hz,1H),7.89-7.81(m,3H),7.67-7.65(m,1H),7.55-7.52(m,2H),7.45-7.37(m,2H),7.26-7.23(m,1H),7.07(t,J=8.0Hz,2H),7.01(d,J=16.0Hz,1H).
13C NMR(100MHz,CDCl3)δ165.9,162.4(d,J=247.0Hz,C-F),149.5,141.9,137.9,137.0,133.1(d,J=3.0Hz,2C),131.3,130.8,128.5(d,J=8.4Hz,2C),128.3,125.8,125.1,124.5,123.8,119.1,115.6(d,J=22.1Hz,2C).
HRMS(EI)计算值:C19H14FNOS(M+)323.0780,检测值:323.0782.
由实施例4制备得到的1,2-二苯乙烯衍生物(I-4)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000101
形状:白色固体;
熔点:158-159℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.49(s,1H),8.29(d,J=16.4Hz,1H),8.07(d,J=7.6Hz,1H),7.90-7.86(m,2H),7.71-7.69(m,1H),7.51-7.45(m,2H),7.30-7.27(m,1H),6.99(d,J=16.4,1H).
13C NMR(100MHz,CDCl3)δ165.6,149.7,142.7,138.0,136.3,132.6(d,C-C6F5),131.5,129.5,126.1,125.3,124.6,119.0,116.2.
HRMS(EI)计算值:C19H10F5NOS(M+)395.0403,检测值:395.0407.
由实施例5制备得到的1,2-二苯乙烯衍生物(I-5)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000111
形状:白色固体;
熔点:137-138℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.47(d,J=4.4Hz,1H),8.00(d,J=7.6Hz,1H),7.91-7.87(m,2H),7.82(td,J1=8.0Hz,J2=1.2Hz,1H),7.67(dd,J1=8.0Hz,J2=1.2Hz,1H),7.57(d,J=8.0Hz,2H),7.43-7.39(m,2H),7.34-7.31(m,1H),7.25-7.22(m,2H),7.02(d,J=15.6Hz,1H),2.29(s,3H).
13C NMR(100MHz,CDCl3)δ169.3,165.9,150.4,149.5,141.8,137.9,136.9,134.6,131.2,130.9,128.3,127.8,125.8,125.0,124.5,124.1,121.8,119.1,21.0.
HRMS(EI)计算值:C21H17NO3S(M+)363.0929,检测值:363.0922.
形状:油状无色液体;
1H NMR(400MHz,CDCl3,TMS)δ8.47(d,J=4.0Hz,1H),8.00(d,J=8.0Hz,1H),7.86(d,J=8.0Hz,1H),8.86-7.77(m,2H),7.66(d,J=7.6Hz,1H),7.50(d,J=9.2Hz,2H),7.43-7.35(m,2H),7.26(m,1H),7.00(d,J=16.4Hz,1H),6.92(d,J=8.8Hz,2H),3.83(s,3H).
13C NMR(100MHz,CDCl3)δ165.9,159.7,149.5,141.4,137.8,137.4,131.6,131.2,129.6,128.2,127.8,125.6,125.0,124.4,121.6,119.1,114.1,55.2.
HRMS(EI)计算值:C20H17NO2S(M+)335.0980,检测值:335.0996.
由实施例7制备得到的1,2-二苯乙烯衍生物(I-7)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000121
形状:黄色固体;
熔点:125-127℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.50(d,J=4.0Hz,1H),8.39(s,1H),8.15(dd,J1=8.0Hz,J2=1.6Hz,1H),8.11-8.06(m,2H),7.94-7.86(m,3H),7.72-7.70(m,1H),7.57(t,J=8.0Hz,1H),7.50-7.43(m,2H),7.30-7.27(m,1H),7.00(d,J=16Hz,1H).
13C NMR(100MHz,CDCl3)δ165.8,149.5,148.6,142.3,138.7,138.1,135.9,132.4,131.3,129.6,129.3,129.0,127.1,126.0,125.1,124.6,122.4,121.6,119.1.
HRMS(EI)计算值:C19H14N2O3S(M+)350.0725,检测值:350.0717.
由实施例8制备得到的1,2-二苯乙烯衍生物(I-8)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000122
形状:黄色固体;
熔点:135-137℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.46(d,J=4.4Hz,1H),8.01(d,J=7.6Hz,1H),7.93(d,J=16.0Hz,1H),7.89(dd,J1=7.6Hz,J2=1.6Hz,1H),,7.84(td,J1=8.0Hz,J2=2.0Hz,1H),7.67(d,J=8.0Hz,1H),7.50(d,J=8.4Hz,2H),7.45-7.39(m,4H),7.27-7.22(m,1H),6.97(d,J=16.0Hz,1H).
13C NMR(100MHz,CDCl3)δ165.9,149.5,142.0,137.9,136.8,135.8,131.8,131.3,130.7,128.5,128.4,125.9,125.2,124.7,124.5,122.0,119.1.
HRMS(EI)计算值:C19H14BrNOS(M+)382.9979,检测值:382.9979.
由实施例11~18(表2)制备得到的苯丙烯酸酯衍生物的结构检测数据分别为:
由表2实施例11制备得到的苯丙烯酸酯衍生物(II-1)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
形状:白色固体;
熔点:76℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.51-8.47(m,2H),8.05(d,J=8.0Hz,1H),7.91-7.85(m,2H),7.63(d,J=8.0Hz,1H),7.49-7.45(m,2H),7.28-7.25(m,1H),6.44(d,J=15.6Hz,1H),3.84(s,3H).
13C NMR(100MHz,CDCl3)δ166.5,165.4,149.7,143.8,139.7,137.9,134.2,131.3,130.6,126.9,125.3,124.4,121.1,118.9,51.7.
HRMS(EI)计算值:C15H13NO3S(M+)287.0616,检测值:287.0614.
由表2实施例12制备得到的苯丙烯酸酯衍生物(II-2)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000132
形状:油状黄色液体;
1H NMR(400MHz,CDCl3,TMS)δ8.50-8.46(m,2H),8.05(d,J=8.0Hz,1H),7.91-7.87(m,2H),7.63(d,J2=2.0Hz,1H),7.49-7.45(m,2H),7.28(m,1H),6.43(d,J=16.0Hz,1H),4.28(m,2H),1.35(m,3H).
13C NMR(100MHz,CDCl3)δ166.5,165.7,150.1,144.1,139.9,138.2,134.6,131.7,130.9,127.2,125.7,124.8,122.0,119.3,61.0,14.5.
HRMS(EI)计算值:C16H15NO3S(M+)301.0773,检测值:301.0763.
由表2实施例13制备得到的苯丙烯酸酯衍生物(II-3)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000141
形状:油状黄色液体;
1H NMR(400MHz,CDCl3,TMS)δ8.51-8.47(m,2H),8.05(d,J=8.0Hz,1H),7.91-7.85(m,2H),7.64(dd,J1=8.0Hz,J2=1.6Hz,1H),7.51-7.43(m,2H),7.29-7.25(m,1H),6.43(d,J=15.6Hz,1H),4.24(t,J=6.8Hz,2H),1.75-1.68(m,2H),1.51-1.42(m,2H),0.97(t,J=7.2Hz,3H).
13C NMR(100MHz,CDCl3)δ166.2,165.4,149.8,143.7,140.0,137.9,134.3,131.3,130.6,126.9,125.3,124.5,121.6,119.0,64.6,30.7,19.1,13.7.
HRMS(EI)计算值:C18H19NO3S(M+)329.1086,检测值:329.1083.
由表2实施例14制备得到的苯丙烯酸酯衍生物(II-4)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000142
形状:油状无色液体;
1H NMR(400MHz,CDCl3,TMS)δ8.55(d,J=15.2Hz,1H),8.45(d,J=4.0Hz,1H),8.18(d,J=8.4Hz,1H),7.88(td,J1=8.0Hz,J2=1.6Hz,1H),7.39-7.35(m,2H),7.27-7.24(m,2H),6.12(d,J=16.0Hz,1H),3.78(s,3H),2.64(s,3H).
13C NMR(100MHz,CDCl3)δ166.8,164.9,150.1,141.4,140.9,140.3,137.4,137.2,133.3,132.1,126.5,124.2,121.5,120.9,52.0,20.2.
HRMS(EI)计算值:C16H15NO3S(M+)301.0773,检测值:301.0786.
由表2实施例15制备得到的苯丙烯酸酯衍生物(II-5)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000151
形状:无色液体;
1H NMR(400MHz,CDCl3,TMS)δ8.42-8.38(m,1H),8.41(d,J=16.0Hz,1H),8.00(d,J=8.0Hz,1H),7.81(td,J1=8.0Hz,J2=1.6Hz,1H),7.70(d,J=8.0Hz,1H),7.40(s,1H),7.25-7.19(m,1H),6.37(d,J=16.0Hz,1H),4.18(t,J=6.8,2H),2.32(s,3H),1.68-1.62(m,2H),1.44-1.38(m,2H),0.92(t,J=7.2Hz,3H).
13C NMR(100MHz,CDCl3)δ166.6,165.9,150.0,142.2,141.0,140.0,138.2,134.5,131.8,127.8,126.0,124.7,121.3,119.3,64.8,30.9,21.6,19.4,13.9.
HRMS(EI)计算值:C19H21NO3S(M+)343.1242,检测值:343.1246.
由表2实施例16制备得到的苯丙烯酸酯衍生物(II-6)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000152
形状:白色固体;
熔点:100-102℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.48(d,J=4Hz,1H),8.41(d,J=15.6Hz,1H),8.00(d,J=7.6Hz,1H),7.89(td,J1=7.6Hz,J2=1.2Hz,1H),7.61(d,J=8.8Hz,1H),7.43(d,J=2.4Hz,1H),7.30-7.26(m,1H),6.96(dd,J1=8.8Hz,J2=2.4Hz,1H),6.35(d,J=16.0Hz,1H),3.84(s,3H),3.82(s,3H).
13C NMR(100MHz,CDCl3)δ166.9,165.3,161.7,149.8,145.5,139.4,137.9,128.3,126.3,124.6,118.9,118.4,118.3,108.5,55.7,51.9.
HRMS(EI)计算值:C16H15NO4S(M+)317.0722,检测值:317.0723.
由实施例17制备得到的苯丙烯酸酯衍生物(II-7)的核磁共振(1HNMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000161
形状:白色固体;
熔点:142-143℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ8.48(d,J=3.2Hz,1H),8.44(d,J=16.0Hz,1H),8.07(d,J=7.6Hz,1H),7.88(t,J=7.6Hz,1H),7.75(d,J=8.8Hz,1H),7.28-7.25(m,1H),7.10(d,J=1.6Hz,1H),6.99(dd,J1=8.8Hz,J2=2.0Hz,1H),6.42(d,J=16.0Hz,1H),3.84(s,3H),3.83(s,3H).
13C NMR(100MHz,CDCl3)δ166.5,165.7,161.9,149.8,139.8,137.9,136.2,135.2,128.0,124.3,121.6,119.1,116.6,111.9,55.5,51.8.
HRMS(EI)计算值:C16H15NO4S(M+)317.0722,检测值:317.0737.
由表2实施例18制备得到的苯丙烯酸酯衍生物(II-8)的核磁共振(1H NMR和13C NMR)检测数据及高分辨质谱(HRMS)检测数据分别为:
Figure BDA0000060416890000162
形状:白色固体;
熔点:128-129℃(未校正);
1H NMR(400MHz,CDCl3,TMS)δ7.47(d,J=3.2Hz,1H),8.41(d,J=16.0Hz,1H),8.04(d,J=8Hz,1H),7.89(td,J1=7.6Hz,J2=1.6Hz,1H),7.84(d,J=8.4Hz,1H),7.61(d,J=1.6Hz,1H),7.44(dd,J1=8.4Hz,J2=2.0Hz,1H),7.31-7.28(m,1H),6.45(d,J=16.0Hz,1H),3.85(s,3H).
13C NMR(100MHz,CDCl3)δ166.2,165.2,149.8,142.3,138.7,138.1,137.7,135.7,130.6,126.8,126.7,124.6,122.3,118.9,51.9.
HRMS(EI)计算值:C15H12ClNO3S(M+)321.0226,检测值:321.0233.

Claims (9)

1.一种苯乙烯衍生物,其结构如式(I)或式(II)所示:
Figure FDA0000060416880000011
式(I)或(II)中R1为甲基、烷氧基、卤原子、H;R2为H、烷氧基、烷酰氧基、硝基、卤原子;R3为C1~C4烷基。
2.根据权利要求1所述的苯乙烯衍生物,其特征在于,所述的式(I)或(II)中:R1为甲基、甲氧基、氯原子、H;R2为H、甲氧基、乙酰氧基、硝基、卤原子;R3为甲基、乙基、正丁基。
3.根据权利要求2所述的苯乙烯衍生物,其特征在于,所述的式(I)或(II)所示的化合物为下列化合物之一:
Figure FDA0000060416880000012
4.一种苯乙烯衍生物的制备方法,包括:搅拌条件下,将2-(苯基亚砜)吡啶化合物(III)、丙烯酸酯化合物(V)或苯乙烯化合物(IV)、醋酸钯、醋酸银加入到乙腈中,50~130℃反应完全;
其中,苯乙烯衍生物的结构式如式(I)或式(II)所示:
Figure FDA0000060416880000042
2-(苯基亚砜)吡啶化合物结构如式(III)所示:
Figure FDA0000060416880000043
苯乙烯化合物结构如式(IV)所示:
Figure FDA0000060416880000051
丙烯酸酯化合物结构如式(V)所示:
Figure FDA0000060416880000052
式(I)、(II)、(III)、(IV)、(V)中,R1为甲基、烷氧基、卤原子、H;R2为H、烷氧基、烷酰氧基、硝基、卤原子;R3为C1~C4烷基。
5.根据权利要求4所述的制备方法,其特征在于,所述的2-(苯基亚砜)吡啶化合物(III)与醋酸钯的摩尔比为1∶0.1~0.5。
6.根据权利要求4所述的制备方法,其特征在于,所述的2-(苯基亚砜)吡啶化合物(III)与苯乙烯化合物(IV)或丙烯酸酯化合物(V)的摩尔比为1∶1~8。
7.根据权利要求4所述的制备方法,其特征在于,所述的2-(苯基亚砜)吡啶化合物(III)与醋酸银的摩尔比为1∶1~5。
8.根据权利要求4所述的制备方法,其特征在于,所述的反应时间为8~25小时。
9.根据权利要求4所述的制备方法,其特征在于,所述的式(III)所示的化合物选自2-(苯基亚砜)吡啶、2-(2-甲基苯基亚砜)吡啶、2-(4-甲基苯基亚砜)吡啶、2-(3-甲氧基苯基亚砜)吡啶、2-(4-甲氧基苯基亚砜)吡啶或2-(4-氯苯基亚砜)吡啶;所述的式(IV)所示的化合物选自苯乙烯、3-硝基苯乙烯、五氟苯乙烯、4-氟苯乙烯、3-氟苯乙烯、4-溴苯乙烯、4-乙酰氧基苯乙烯或4-甲氧基苯乙烯;所述的式(V)所示的化合物选自丙烯酸甲酯、丙烯酸乙酯或丙烯酸正丁酯。
CN2011101203599A 2011-05-11 2011-05-11 一种苯乙烯衍生物及其制备方法 Pending CN102267941A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011101203599A CN102267941A (zh) 2011-05-11 2011-05-11 一种苯乙烯衍生物及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011101203599A CN102267941A (zh) 2011-05-11 2011-05-11 一种苯乙烯衍生物及其制备方法

Publications (1)

Publication Number Publication Date
CN102267941A true CN102267941A (zh) 2011-12-07

Family

ID=45050423

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011101203599A Pending CN102267941A (zh) 2011-05-11 2011-05-11 一种苯乙烯衍生物及其制备方法

Country Status (1)

Country Link
CN (1) CN102267941A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114591228A (zh) * 2022-02-11 2022-06-07 浙江大学杭州国际科创中心 一种手性苯乙烯基吡啶基亚砜及其合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884508A1 (en) * 2006-07-28 2008-02-06 Portela & Ca., S.A. Process for the preparation of polyhydroxylated stilbenes via claisen condensation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884508A1 (en) * 2006-07-28 2008-02-06 Portela & Ca., S.A. Process for the preparation of polyhydroxylated stilbenes via claisen condensation

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ALFONSO GARCIA-RUBIA等: "2-Pyridyl Sulfoxide: AVersatile and Removable Directing Group for the PdII-Catalyzed Direct C-H Olefination of Arenes", 《CHEMISTRY A EUROPEAN JOURNAL》 *
MING YU等: "Palladium(II)-Catalyzed Direct Alkenylation and Arylation of Arenes: Removable 2-Pyridylsulfinyl Group Assisted C-H Bond Activation", 《THE JOURNAL OF ORGANIC CHEMISTRY》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114591228A (zh) * 2022-02-11 2022-06-07 浙江大学杭州国际科创中心 一种手性苯乙烯基吡啶基亚砜及其合成方法

Similar Documents

Publication Publication Date Title
Wang et al. A highly efficient palladium-catalyzed desulfitative arylation of azoles with sodium arylsulfinates
Rasheed et al. Sulphuric acid immobilized on silica gel (H 2 SO 4–SiO 2) as an eco-friendly catalyst for transamidation
Zhang et al. Recyclable palladium (II) imino-pyridine complex immobilized on mesoporous silica as a highly active and recoverable catalyst for Suzuki–Miyaura coupling reactions in aqueous medium
Zhang et al. Highly efficient cyclopalladated ferrocenylimine catalyst for Suzuki cross-coupling reaction of 3-pyridylboronic pinacol ester with aryl halides
Hopkinson et al. Gold-catalyzed diastereoselective synthesis of α-fluoroenones from propargyl acetates
Teo et al. Efficient ligand-free, copper-catalyzed N-arylation of sulfonamides
Peng et al. A 2, 2′-bipyridine-palladacycle catalyzed the coupling of arylboronic acids with nitroarenes
Linsenmeier et al. Efficient one-pot synthesis of dihydroquinolinones in water at room temperature
Patpi et al. Pd-catalyzed site selective C–H acetoxylation of aryl/heteroaryl/thiophenyl tethered dihydroquinolinones
CN109096162B (zh) 一种钪催化硫醇对邻亚甲基苯醌的亲核加成反应方法
JP4929468B2 (ja) クロスカップリング反応を用いたオリゴマー化合物の合成方法
Qin et al. Suzuki-Miyaura cross-coupling of arenediazonium salts with arylboronic acids catalyzed by a recyclable polymer-supported N-heterocyclic carbene-palladium catalyst
CN102267941A (zh) 一种苯乙烯衍生物及其制备方法
JP5180596B2 (ja) スルホニルイミデートを求核剤とする反応方法
CN108912076A (zh) 一种苯并氧杂环化合物的合成方法
Liu et al. Amide as an efficient ligand in the palladium-catalyzed Suzuki coupling reaction in water/ethanol under aerobic conditions
Majumdar et al. Novel synthesis of oxathiocine derivatives by wittig olefination and intramolecular Heck reaction via an 8-endo-trig cyclization
Wu et al. A highly efficient memantine-modified palladium catalyst for Suzuki–Miyaura cross-coupling reaction
CN102336763B (zh) 一种吡喃香豆素衍生物的合成方法
Malik et al. Synthesis of 7, 8-diarylflavones by site-selective Suzuki-Miyaura reactions
Huang et al. Stereoselective aminobromination of alkylidenecyclopropanes with TsNH2 and NBS as nitrogen and bromine sources: a simple access to γ-bromohomoallylic sulfonamides
Saiyed et al. Amino oxazolines as easily accessible water stable ligands for palladium catalysed aqueous Heck reaction
CN114075108A (zh) 醛的氘代和制备氘代醛中的应用
CN102304056B (zh) 3-甲基-4-芳基-3-烯-丁酰五氟苯胺衍生物及制备方法
Han et al. Synthesis of Sulfoximines through Selective Sulfur Alkylation of Sulfinamides Generated In Situ from β-Sulfoximine Esters

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20111207